160 related articles for article (PubMed ID: 26894969)
1. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.
Wei ZR; Liang C; Feng D; Cheng YJ; Wang WM; Yang DJ; Wang YX; Cai QP
Oncotarget; 2016 Apr; 7(14):17737-50. PubMed ID: 26894969
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
3. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.
Sun XJ; Liu BY; Yan S; Jiang TH; Cheng HQ; Jiang HS; Cao Y; Mao AW
Cell Physiol Biochem; 2015; 37(2):707-18. PubMed ID: 26356262
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.
Deng K; Wang H; Shan T; Chen Y; Zhou H; Zhao Q; Xia J
Sci Rep; 2016 Apr; 6():24505. PubMed ID: 27074834
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
[TBL] [Abstract][Full Text] [Related]
8. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
9. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
10. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
11. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells.
Dong F; Li C; Wang P; Deng X; Luo Q; Tang X; Xu L
Exp Cell Res; 2018 Jun; 367(1):89-96. PubMed ID: 29577897
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13.
Zeng B; Zhu D; Su Z; Li Z; Yu Z
Int Immunopharmacol; 2016 Oct; 39():63-70. PubMed ID: 27424080
[TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
[TBL] [Abstract][Full Text] [Related]
15. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
17. The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells.
Bros M; Wiechmann N; Besche V; Art J; Pautz A; Grabbe S; Kleinert H; Reske-Kunz AB
Mol Immunol; 2010 Feb; 47(5):1161-70. PubMed ID: 19945750
[TBL] [Abstract][Full Text] [Related]
18. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
19. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
[TBL] [Abstract][Full Text] [Related]
20. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
